Trail Ridge Investment Advisors, LLC Amgen Inc Transaction History

Trail Ridge Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	SELL	$255.7 - $288.46 $5,625 - $6,346	-22 Reduced 1.14%	1,904 $548,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $1,967 - $2,443	9 Added 0.47%	1,926 $517,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $33,211 - $39,272	-155 Reduced 7.48%	1,917 $425,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $126,668 - $154,387	-561 Reduced 21.31%	2,072 $500,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $57,257 - $72,752	250 Added 10.49%	2,633 $691,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $31,199 - $35,187	-139 Reduced 5.51%	2,383 $679,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $122,571 - $135,596	-559 Reduced 18.14%	2,522 $609,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $612,749 - $701,235	3,081 New	3,081 $693,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Trail Ridge Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Trail Ridge Investment Advisors, LLC with notifications on news.